Smartleaf Asset Management LLC raised its holdings in shares of Okta, Inc. (NASDAQ:OKTA – Free Report) by 40.2% in the 4th ...

LifeMD Inc (LFMD) reports a 43% revenue increase and unveils plans for new product launches and Medicare offerings amid ...

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

LSU Health Shreveport has announced the Rapides Health Project, which works by providing a free three-month supply of GLP-1 agonists. You may know these by other names, such as Semaglutide, Mounjaro ...

West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

Scientists have discovered a naturally-occurring molecule that aids appetite control and weight loss so well, it may compete with popular GLP-1 agonists like Ozempic.

A new study presented at the American Academy of Orthopedic Surgeons meeting reveals the need to stop taking GLP-1 agonists ...

Over the past decade researchers have uncovered significant links between many of our most commonly used drugs - and patients ...

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the three and 12 months ended ...

Increasing access to these effective evidence-based treatments would benefit our society as a whole, not just those impacted ...

There's the final part of The Skinny Jab Revolution, new series Chess Masters: The Endgame, Michael Sheen's Secret Million ...